Delta Eight Pharmaceuticals

Delta Eight Pharmaceuticals is pursuing a license for the commercial production of medical Marijuana under the A.C.M.P.R. in Canada. The research, development and successful marketing of Cannabis based pharmaceuticals is the primary focus of our future plans. Our mission is twofold: i) To provide an abundant and consistent supply of superior grade medical Cannabis (Marijuana) to those eligible to receive it under the law. ii) To research and compete on the cutting edge of Cannabinoid science to provide the best products for our patients as permitted by Health Canada guidelines.